Source: EIN Presswire

Press Release: Tx3 : Tx3 Services and Apexon Form Strategic Life Sciences Partnership

Tx3 Services and Apexon combine their experience, solutions, and Life Sciences practices to service FDA regulated organizations. DOYLESTOWN, PA, UNITED STATES, September 14, 2021 /⁨EINPresswire.com⁩/ -- In a continued effort to expand digital technology ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jason Tepfenhardt's photo - Co-Founder & CEO of Tx3

Co-Founder & CEO

Jason Tepfenhardt

CEO Approval Rating

87/100

Read more